Latest filingSep 02, 2026Most recent Form 4
ANTX
AN2 Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$1.16M1 buys
Total selling$21.2M2 sells
Net open-market-$20.1M2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period3transactions
- S · Open-market sells · dominant2 · 67%
- P · Open-market buys1 · 33%
Activity by reported role
A joint filing can contribute to multiple roles3transactions
- Director · dominant3 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeReadnour Robin ShaneCommon Stock · Indirect · See footnotes
633,867Aug 17, 2026
FitzPatrick Margaret MCommon Stock · Direct
10,708Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- RS-$212.7k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
ANTX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ANTX | Readnour Robin Shane | DIR | sale10b5-1 | 18.7k | -$11.2M | S | −8.1% | 08/19 | 08/17 | |
| ANTX | Readnour Robin Shane | DIR | sale10b5-1 | 16.6k | -$10.0M | S | −8.1% | 08/19 | 08/17 |
AN2 Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at AN2 Therapeutics, Inc.?
FitzPatrick Margaret M, Readnour Robin Shane.
When was the latest reported open-market purchase?
FitzPatrick Margaret M reported a buy on Sep 01, 2026 valued at $1.16M. Read the SEC filing.
When was the latest reported open-market sale?
Readnour Robin Shane reported a sale on Aug 17, 2026 valued at $11.2M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $201,100.36. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.